FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation Read more
Biocon and Equillium expand exclusive licensing agreement for Itolizumab to include Australia and New Zealand Read more
Biomedical engineers develop system that allows for real-time observations of individual cells in colon Read more
Selatogrel, alternative treatment for early stages heart attack: University of Sheffield Cardiovascular Research Unit Read more